Genmab A/S (GMAB)
26.19
-0.22
(-0.83%)
USD |
NASDAQ |
Jun 14, 16:00
26.21
+0.02
(+0.08%)
After-Hours: 20:00
Genmab Price to Book Value: 3.580 for June 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 3.580 |
| June 13, 2024 | 3.610 |
| June 12, 2024 | 3.659 |
| June 11, 2024 | 3.734 |
| June 10, 2024 | 3.816 |
| June 07, 2024 | 3.795 |
| June 06, 2024 | 3.902 |
| June 05, 2024 | 3.928 |
| June 04, 2024 | 3.895 |
| June 03, 2024 | 3.940 |
| May 31, 2024 | 3.854 |
| May 30, 2024 | 3.839 |
| May 29, 2024 | 3.839 |
| May 28, 2024 | 3.842 |
| May 24, 2024 | 3.841 |
| May 23, 2024 | 4.029 |
| May 22, 2024 | 4.094 |
| May 21, 2024 | 4.003 |
| May 20, 2024 | 4.077 |
| May 17, 2024 | 4.117 |
| May 16, 2024 | 4.072 |
| May 15, 2024 | 4.150 |
| May 14, 2024 | 4.055 |
| May 13, 2024 | 4.007 |
| May 10, 2024 | 3.963 |
| Date | Value |
|---|---|
| May 09, 2024 | 3.959 |
| May 08, 2024 | 3.957 |
| May 07, 2024 | 4.024 |
| May 06, 2024 | 3.988 |
| May 03, 2024 | 4.083 |
| May 02, 2024 | 3.813 |
| May 01, 2024 | 3.954 |
| April 30, 2024 | 3.809 |
| April 29, 2024 | 3.930 |
| April 26, 2024 | 3.872 |
| April 25, 2024 | 3.788 |
| April 24, 2024 | 3.928 |
| April 23, 2024 | 3.940 |
| April 22, 2024 | 3.997 |
| April 19, 2024 | 3.960 |
| April 18, 2024 | 3.917 |
| April 17, 2024 | 3.944 |
| April 16, 2024 | 4.069 |
| April 15, 2024 | 4.08 |
| April 12, 2024 | 4.045 |
| April 11, 2024 | 4.116 |
| April 10, 2024 | 4.146 |
| April 09, 2024 | 4.148 |
| April 08, 2024 | 4.133 |
| April 05, 2024 | 4.119 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.580
Minimum
Jun 14 2024
10.98
Maximum
Sep 04 2019
7.136
Average
7.065
Median
Dec 14 2021
Price to Book Value Benchmarks
| Ascendis Pharma A/S | -- |
| Novo Nordisk A/S | 44.36 |
| Galecto Inc | 0.5103 |
| Evaxion Biotech AS | 3.032 |
| IO Biotech Inc | 0.7474 |
Price to Book Value Related Metrics
| PE Ratio | 21.70 |
| PS Ratio | 6.672 |
| PEG Ratio | 2.092 |
| Price to Free Cash Flow | 22.06 |
| Price | 26.19 |
| Earnings Yield | 4.61% |
| Market Cap | 16.83B |
| PEGY Ratio | 2.092 |
| Operating PE Ratio | 20.85 |
| Normalized PE Ratio | 23.38 |